This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Nishiyama, T. Articles by Hanaoka, K. Search for Related Content PubMed PubMed Citation Articles by Nishiyama, T. Articles by Hanaoka, K. Related Collections Regional Anesthesia Pain Pharmacology

---

PAIN MEDICINE

Intrathecal Clonidine and Bupivacaine Have Synergistic Analgesia for Acute Thermally or Inflammatory-Induced Pain in Rats

From the Department of Anesthesiology, The University of Tokyo, Faculty of Medicine, Tokyo, Japan

Address correspondence and reprint requests to Tomoki Nishiyama, MD, PhD, Department of Anesthesiology, The University of Tokyo, Faculty of Medicine, 7–3-1, Hongo, Bunkyo-ku, Tokyo, 113–8655, Japan. Address email to nishit-tky{at}umin.ac.jp

We investigated the interaction between spinally administered bupivacaine and clonidine using an animal model of acute and inflammatory pain. Rats implanted with lumbar intrathecal catheters were injected intrathecally with saline (control), bupivacaine (1 to 100 µg), or clonidine (0.1 to 3 µg) and tested for their responses to thermal stimulation to the tail (tail flick test) and subcutaneous formalin injection into the hindpaw (formalin test). The effects of the combination of bupivacaine and clonidine on both stimuli were tested by isobolographic analysis. General behavior and motor function were examined as side effects. The 50% effective doses of bupivacaine and clonidine were significantly smaller when combined compared with each single drug in both the tail flick test (2.82 and 0.11 µg versus 7.1 and 0.29 µg, respectively) and phase 1 (0.24 and 0.009 µg versus 5.7 and 0.15 µg) and phase 2 (0.31 and 0.012 µg versus 3.2 and 0.16 µg) of the formalin test. Side effects were decreased by the combination. These results suggest a favorable combination of intrathecal bupivacaine and clonidine in the management of acute and inflammatory pain.

IMPLICATIONS: The analgesic interaction between intrathecally administered bupivacaine and clonidine was examined during acute thermal and inflammatory-induced pain in rats. The analgesia produced by the combination of these two drugs was synergistic in both acute thermal and inflammatory induced pain, with a decrease in behavioral side effects.

This article has been cited by other articles:

				S. Kang, C. H. Kim, H. Lee, D. Y. Kim, J. I. Han, R. K. Chung, and G. Y. Lee Antinociceptive Synergy Between the Cannabinoid Receptor Agonist WIN 55,212-2 and Bupivacaine in the Rat Formalin Test Anesth. Analg., March 1, 2007; 104(3): 719 - 725. [Abstract] [Full Text] [PDF]